1. Home
  2. NGVC vs TBPH Comparison

NGVC vs TBPH Comparison

Compare NGVC & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Grocers by Vitamin Cottage Inc.

NGVC

Natural Grocers by Vitamin Cottage Inc.

HOLD

Current Price

$31.04

Market Cap

757.8M

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$16.84

Market Cap

908.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NGVC
TBPH
Founded
1955
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
757.8M
908.9M
IPO Year
2012
2013

Fundamental Metrics

Financial Performance
Metric
NGVC
TBPH
Price
$31.04
$16.84
Analyst Decision
Strong Buy
Buy
Analyst Count
1
6
Target Price
$36.00
$18.40
AVG Volume (30 Days)
106.3K
911.9K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
2.16%
N/A
EPS Growth
36.05
279.13
EPS
1.07
N/A
Revenue
N/A
$15,386,000.00
Revenue This Year
$7.08
$8.46
Revenue Next Year
$6.04
N/A
P/E Ratio
$29.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.47
$10.82
52 Week High
$45.98
$21.03

Technical Indicators

Market Signals
Indicator
NGVC
TBPH
Relative Strength Index (RSI) 46.25 49.67
Support Level $30.36 $16.17
Resistance Level $31.94 $17.21
Average True Range (ATR) 1.15 0.11
MACD -0.27 -0.04
Stochastic Oscillator 13.51 8.33

Price Performance

Historical Comparison
NGVC
TBPH

About NGVC Natural Grocers by Vitamin Cottage Inc.

Natural Grocers by Vitamin Cottage Inc operates natural and organic grocery and dietary supplement stores. It offers the following product categories: natural and organic food, dietary supplements, natural body care, household, pet care products, books, and handouts. The Company has a single reporting segment, natural and organic retail stores, through which business is conducted. The company generates the majority of its revenue from grocery products and dietary supplements, and the rest from other products.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Share on Social Networks: